Awarded
Automated Solution to Develop and Optimise Upstream Processes
Descriptions
VMIC requires the ability to rapidly develop and optimise upstream processes using a state-of-the-art Quality by Design (QBD) approach to ensure robustness as well as rapid development. The ability to execute a Design of Experiments (DoE) approach is integral to the assurance of robustness and furthermore ensures that the processes developed are well away from the edge of failure. VMIC will be a centre of excellence for vaccine development in the UK, and must also have the capability to respond rapidly to pandemic situations, therefore it requires a solution that will allow rapid development of robust processes for clients whilst also allowing a significant reduction in operator-hours and time to create credible processes for anti-pandemic vaccine candidates.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
CPV Codes
38434540 - Biomedical equipment
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
biomedical equipment
clinical diagnostic devices
life science instruments
medical lab apparatus
patient monitoring lab gear
research biomedical units
Tender Lot Details
2 Tender Lots
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
Tenderbase ID :
Low Value :
High Value :
Buyer Information
Procurement contact
Name :
Phone :
Email :
Possible Competitors
1 Possible Competitors
